Lipocine Investor Room https://ir.lipocine.com/ Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154 https://ir.lipocine.com/2026-06-04-Lipocine-Inc-to-Host-Virtual-KOL-Event-Highlighting-Unmet-Needs-in-Postpartum-Depression-and-the-Clinical-Profile-of-LPCN-1154 Thu, 04 Jun 2026 08:00:00 -0400 https://ir.lipocine.com/2026-06-04-Lipocine-Inc-to-Host-Virtual-KOL-Event-Highlighting-Unmet-Needs-in-Postpartum-Depression-and-the-Clinical-Profile-of-LPCN-1154 Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting https://ir.lipocine.com/2026-05-19-Lipocine-Announces-LPCN-1154-Phase-3-Data-Accepted-for-Oral-Presentation-at-2026-ASCP-Annual-Meeting Tue, 19 May 2026 08:00:00 -0400 https://ir.lipocine.com/2026-05-19-Lipocine-Announces-LPCN-1154-Phase-3-Data-Accepted-for-Oral-Presentation-at-2026-ASCP-Annual-Meeting Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase https://ir.lipocine.com/2026-05-18-Lipocine-to-Present-at-A-G-P-s-Annual-Virtual-Healthcare-Company-Showcase Mon, 18 May 2026 08:00:00 -0400 https://ir.lipocine.com/2026-05-18-Lipocine-to-Present-at-A-G-P-s-Annual-Virtual-Healthcare-Company-Showcase Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026 https://ir.lipocine.com/2026-05-07-Lipocine-Announces-Financial-Results-for-the-First-Quarter-Ended-March-31,-2026 Thu, 07 May 2026 16:05:00 -0400 https://ir.lipocine.com/2026-05-07-Lipocine-Announces-Financial-Results-for-the-First-Quarter-Ended-March-31,-2026 Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression https://ir.lipocine.com/2026-04-02-Lipocine-Reports-Topline-Safety-and-Efficacy-Results-for-LPCN-1154-in-Patients-with-Postpartum-Depression Thu, 02 Apr 2026 08:00:00 -0400 https://ir.lipocine.com/2026-04-02-Lipocine-Reports-Topline-Safety-and-Efficacy-Results-for-LPCN-1154-in-Patients-with-Postpartum-Depression